Changes in the lipidome in type 1 diabetes following low carbohydrate diet: a randomized crossover trial

Naba Al-Sari; Signe Schmidt; Tommi Suvitaival; Min Kim; Kajetan Trošt; Ajenthen G. Ranjan; Merete B. Christensen; Anne Julie Overgaard; Flemming Pociot; Kirsten Nørgaard; Cristina Legido-Quigley

doi:10.1101/2020.09.17.20196394

Abstract

Aims/hypothesis Lipid metabolism might be compromised in type 1 diabetes and the understanding of lipid physiology is critically important. This study aimed to compare the change in plasma lipid concentrations during carbohydrate dietary changes in individuals with type 1 diabetes and identify links to early-stage dyslipidaemia. We hypothesized that: (1) the lipidomic profiles after ingesting low or high carbohydrate diet for 12 weeks would be different; and (2) specific annotated lipid species could have significant associations with metabolic outcomes.

Methods Ten adults with type 1 diabetes (mean±SD: age 43.6±13.8 years, diabetes duration 24.5±13.4 years, BMI 24.9±2.1 kg/m², HbA_1c 57.6±2.6 mmol/mol) using insulin pumps participated in a randomized 2-period crossover study with a 12-week intervention period of low carbohydrate diet (< 100 g carbohydrates/day) or high carbohydrate diet (> 250 g carbohydrates/day) respectively, separated by a 12-week washout period. A large-scale non-targeted lipidomics was performed with mass spectrometry in fasting plasma samples obtained before and after each diet intervention. Longitudinal lipid levels were analysed using linear mixed-effects models.

Results In total, 289 lipid species were identified from 14 major lipid classes (triacylglycerides, phosphatidylcholines, phosphatidylethanolamines, hexosyl-ceramide, sphingomyelins, lyso-phosphatidylcholines, ceramides, lactosyl-ceramide, lyso-phoshatidylethanolamine, free fatty acids, phosphatidylinositols, phosphatidylglycerols, phosphatidylserines and sulfatides). Comparing the two diets, 11 lipid species belonging to sphingomyelins, phosphatidylcholines and LPC(O-16:0) were changed. All the 11 lipid species were significantly elevated during low carbohydrate diet. Two lipid species were most differentiated between diets, namely SM(d36:1) (β±SE: 1.44±0.28, FDR = 0.010) and PC(P-36:4)/PC(O-36:5) (β±SE: 1.34±0.25, FDR = 0.009) species. Poly-unsaturated PC(35:4) was inversely associated with BMI and positively associated with HDL-cholesterol (p < 0.001).

Conclusion/interpretation Lipidome-wide outcome analysis of a randomized cross-over trial of individuals with type 1 diabetes following a low carbohydrate diet showed an increase in sphingomyelins and phosphatidylcholines which are thought to reduce dyslipidaemia. The poly-unsaturated phosphatidylcholine 35:4 was inversely associated with BMI and positively associated with HDL-cholesterol (p < 0.001). Results from this study warrant for more investigation on the long-term effect of single lipid-species in type 1 diabetes.

Trial registration Clinicaltrials.gov NCT02888691

Research in context

What is already known about this subject?

What is already known about this subject?

Individuals with type 1 diabetes have an increased rate of cardiovascular disease for which dyslipidaemia is a major risk factor.
Dysregulated lipid metabolism is recognized as an established risk factor in cardiovascular diseases.

What is the key question?

What is the key question?

Which specific circulating lipid species are changed after 12 weeks of low- and –high carbohydrate diet and do they reflect dyslipidaemia risk?

What are the new findings?

What are the new findings?

Plasma from individuals with type 1 diabetes showed a significant increase in phosphatidylcholine and sphingomyelin lipid species during low carbohydrate diet (n=11 lipid species).
Poly-unsaturated phosphatidylcholine 35:4 was inversely associated with BMI and positively associated with HDL-cholesterol (p < 0.001).

How might this impact on clinical practice in the foreseeable future?

How might this impact on clinical practice in the foreseeable future?

This study demonstrates that unsaturated phosphatidylcholines and monounsaturated sphingomyelins were elevated with diet in individuals with type 1 diabetes following low carbohydrate diet. This points to a need for lipid-specific dietary guidelines regarding fat intake to support individuals with type 1 diabetes.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT02888691

Funding Statement

The lipidomics study did not receive any particular funding. The clical trial was funded by a research grant from the Danish Diabetes Academy supported by the Novo Nordisk Foundation, the Danish Diabetes Association, Vissing Fonden, and The A.P. Moller Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was approved by the Regional Scientific Ethics Committee (H-16032632), the Danish Data Protection Agency (AHH-2015-002), and registered at ClinicalTrials.gov (NCT02888691).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes